Date authorised
1 April 2013
Companies House
00911235
Last scraped
3 weeks ago
Watch for changes

Addresses

The contact details this firm has registered with the FCA.

  • Principal Place of Business

    A-B Mill
    Dean Clough Mills
    Halifax
    Calderdale
    HX3 5AX
    UNITED KINGDOM
    Phone
    +4403302210444
  • Complaints Contact

    A-B Mill
    Dean Clough Mills
    Halifax
    Calderdale
    HX3 5AX
    UNITED KINGDOM
    Phone
    +4403302210444

What this firm is allowed to do

The regulated activities the FCA has granted this firm permission to carry out.

  • Bank Deposits

    For All, Deposit

    Show 1 limitation
    • · Limited to accepting deposits in the course of carrying on insurance business for which the firm holds a permission.
  • Investment Advice (no pensions)

    For Commercial, Retail (Non-Investment Insurance), Non-investment insurance contracts

  • Authorised to Operate

    Show 1 limitation
    • · The firm can only agree to carry on the regulated activities specified in this Notice.
  • Arranges Investments

    For Commercial, Retail (Non-Investment Insurance), Non-investment insurance contracts

  • Manages Insurance Policies

    For All, Capital redemption, Life and annuity, Permanent health

  • Trades With You Directly

    For Eligible Counterparty, Professional, Retail (Investment), Commodity Future, Commodity option and option on commodity future, Contract for Differences (excluding a spread bet and, a rolling spot forex contract and a binary bet), Future (excluding a commodity future and a rolling spot forex contract), Option (excluding a commodity option and an option on a commodity future), Rights to or interests in investments (Contractually Based Investments), Rolling spot forex contract, Spread Bet

    Show 2 limitations
    • · Investment activity in "rights to or interests in investments (contractually based)" is limited to investment types granted for this activity.
    • · The firm, in carrying out this regulated activity, is limited to entering into transactions in a manner which, if the firm was an unauthorised person, would come within article 16 of the RAO.
  • Issues Insurance

    For All, Capital redemption, Life and annuity, Permanent health

  • Investment Setup

    For Commercial, Retail (Non-Investment Insurance), Non-investment insurance contracts

Approved individuals

Senior staff personally approved by the FCA to hold their roles here.

  • Henry James Kenyon

    IRN HJK01021

    • SIMF11 Chair of the Audit Committee (7 Mar 2016 to 31 Mar 2017)
    • CF2 Non Executive Director (24 Feb 2015 to 6 Mar 2016)
  • Ian James Clifford Bubb

    IRN IXB44290

    • SMF24 Chief Operations (17 Nov 2023 to 28 Jun 2024)
  • James Tobin Gearey

    IRN JTG01034

    • Responsible for Insurance Distribution (27 Aug 2020 to 31 Aug 2022)
    • SMF3 Executive Director (20 Apr 2020 to 31 Aug 2022)
    • SMF18 Other Overall Responsibility (4 Sep 2019 to 12 Jun 2020)
  • James William Reader

    IRN JWR01079

    • SMF1 Chief Executive (10 Dec 2018 to 21 Jul 2021)
    • SIMF1 Chief Executive Function (8 Aug 2016 to 9 Dec 2018)
    • CF1 Director (24 Feb 2015 to 8 Aug 2016)
  • Jane Dale

    IRN JED01078

    • SMF11 Chair of the Audit Committee (10 Dec 2018 to 31 Mar 2026)
    • SIMF11 Chair of the Audit Committee (21 Feb 2017 to 9 Dec 2018)
  • Jeffrey Niven Herdman

    IRN JNH01057

    • SMF10 Chair of the Risk Committee (since 3 Oct 2023)
  • Joanne King

    IRN JXK00475

    • [FCA CF] Significant management (since 5 Nov 2022)
  • Joanne Shaw

    IRN JXS00648

    • [FCA CF] Significant management (1 Jan 2021 to 13 Sep 2024)
  • John Alfred George Knapp

    IRN JAK01080

    • CF1 Director (10 May 2002 to 21 Jan 2009)
  • John Allen

    IRN JXA01872

    • SMF2 Chief Finance (31 Jan 2023 to 16 Oct 2023)
    • [FCA CF] Significant management (10 Dec 2018 to 31 Jan 2023)

Appointed representatives

Smaller firms operating under this firm's FCA authorisation.

Recent activity

Updates to this firm's record on the FCA register.

No changes recorded yet.